Pay in 4 interest-free payments of $6.88 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Tirzepatide: Dual GIP/GLP-1 Receptor Agonism Tirzepatide (LY3298176) is a synthetic 39-amino-acid peptide engineered as a dual agonist of the glucose-dependent insulinotropic polypeptide receptor (GIPR) and the glucagon-like peptide-1 receptor (GLP-1R), with a C20 fatty diacid moiety for albumin binding
Nausea, diarrhea, decreased appetite, and vomiting were reported more frequently in the tirzepatide groups compared to the insulin degludec group
Clinical trials leading to FDA approval demonstrated significant visceral fat reduction in patients with excess abdominal fat accumulation, validating what clinicians now see consistently in practice
The best choice depends on your health history, how your body responds, and what your licensed healthcare provider recommends
Polycystic ovaries Lastly, an ultrasound scan is done to check for an enlarged ovary and/or the presence of multiple cysts in the ovaries
US$ 24.81
US$ 28.37
US$ 20.54
US$ 23.37
US$ 20.96
US$ 29.82
US$ 21.60
US$ 28.98
US$ 29.55
